This article is more than 5 years old. Information may no longer be current.

Alphaeon names Bob Rhatigan chief operating officer

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Bob Rhatigan has joined Alphaeon as its chief operating officer, the company announced in a news release.

In his position as COO, Rhatigan will play a prominent role in the development of Alphaeon’s commercial execution and future growth.

“Bob has an outstanding track record of successful business leadership in medical aesthetics and will add tremendous value as Alphaeon continues its rapid expansion to become the leader in providing innovative products and services in the lifestyle health care market,” Robert E. Grant, CEO of Alphaeon, said in the release.

Rhatigan previously served as senior vice president, general manager and chief executive of SkinMedica. He was responsible for the integration of SkinMedica into Allergan and led all facets of SkinMedica’s operation, including research and development, commercialization, manufacturing and operations.

He also served as senior vice president of Allergan’s facial aesthetics business and oversaw the launch of Botox (onabotulinumtoxinA) and Latisse (bimatoprost ophthalmic solution 0.03%) in the United States.